The Health Care Institute of New Jersey counts among its members some of the world’s most prominent life sciences companies. This concentration of expertise and capabilities puts the state on the front lines of the fight against the COVID-19 pandemic. NJBIZ Editor Jeff Kanige recently spoke about the battle with HINJ President and Chief Executive Officer Dean Paranicas. “Both the biopharma companies and the medical technology companies, they’re on the ground, they’ve been at this hard,” Paranicas said. “They’ve been at this from the beginning. They never close. They kept on working through, developing diagnostic tests and working on therapies and, of course, working on a vaccine.”
Watch the whole interview here.